COOPERATION OPPORTUNITIES BETWEEN THE EU AND THE EAP PARTNER COUNTRIES ON COVID-19 RELATED RESEARCH AND INNOVATION ACTIONS
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
Cooperation opportunities between the EU
and the EaP partner countries on COVID-19
related research and innovation actions
Rosanna D’Amario
Senior Expert, Sector ‘Stakeholder
Eastern Partnership Engagement and Communication’
Panel on research and innovation DG Research & Innovation
10 December 2020 European Commission, BrusselsOverview
European response to COVID-19
International cooperation on COVID-19 R&I
Horizon Europe: Health Cluster
2EC response to Covid-19 – funding R&I
30 January 2020:
• WHO declaration of an Public Health Emergency of International Concern
• 1st Emergency call for Expression of interest (EoI): €48 million => 18 projects
(preparedness, diagnostics, treatments, vaccines)
31 March 2020
• Innovative Medicines Initiative (IMI) call: €72m => 8 projects (diagnostics and
treatments)
19 May 2020:
• 2nd Emergency call for EoI: €128m => 23 projects
to strengthen and adapt industrial capacity to manufacture and deploy
equipment, to develop medical technologies and digital tools, to better
understand the societal impacts of the pandemic, and to learn from large groups
3 of patients (cohorts).EC response to Covid-19 – funding R&I
• July-November 2020:
• Contribution to CEPI*: €100m for vaccine dev. (*Coalition for Epidemic
Preparedness Innovations)
• European Innovation Council (EIC) Accelerator pilot: €165m for 36 SME-led
projects
• EIT Crisis Response Initiative: €60 million for 207 innovation projects
• Financing via InnovFin Infection Diseases Financial Facility (IDFF):
• CureVac: €75m for vaccine development
• BioNTech: €100m for vaccine development (with Pfizer)
• Other companies
• Total commitment in 2020:
• €1 billion in R&I grants
• €400 million in financing
4EC response to Covid-19 – Policy action
• Policy actions:
• 7 April 2020 – “ERAvsCorona” action plan
• 4 May 2020 – Coronavirus Global response
• 14 May 2020 – European Research Area (ERA) corona platform
• April 2020 – COVID-19 Data Portal launched
• 10 June 2020 – EU strengthens action to tackle disinformation
• 17 June 2020 – Commission unveils EU vaccines strategy
• 28 July 2020 – Manifesto for EU COVID-19 research for accessibility of results
• 11 Nov. 2020 – Investment in Preparedness and response to infectious disease outbreaks
(Building a European Health Union), including research & innovation on preparedness
=> input towards Horizon EuropeInternational cooperation: GloPID-R (1) Global Research Collaboration for Infectious Diseases Preparedness Importance of cooperating at funding agency level GloPID-R has 29 members worldwide plus other entities actively involved: World Health Organization, the Coalition for Epidemic Preparedness Innovations (CEPI) and the European & Developing Countries Clinical Trials Partnership (EDCTP) The dialogue among the 29 funding members led the European Commission to rapidly launch a call (1st Expression of interest on 30 January 2020) 6
International cooperation: Third countries in
COVID-19 calls
First and second expressions of interest and IMI call
Calls, despite the short deadline, were open to participation of entities
established in Third countries
In the three calls there were 24 participations from 14 Third countries (China
was the first, with six participations)
Some projects are providing results!
HG-nCoV19 test: 1-hour test launched in May; dual test with flu announced in
December
7International cooperation: opportunities for
cooperation on COVID-19
Opportunities to exchange information among agencies and funded projects
(e.g. RTD colleagues organised a workshop on June 2020)
Possibility to join existing networks, such as GloPID-R, by getting in touch
with the Chair of the network
Joining the live database of funded research projects across the world
related to the current COVID-19 pandemic at the COVID-19 Research
Project Tracker
Using the European COVID-19 Data Platform that facilitates data sharing and
analysis in order to accelerate coronavirus research
8Cooperation with EaP countries
Country Organisation Project
Armenia Center of Medical Genetics and Primary Health Care COFUND-EJP
Georgia GEORGIAN FOUNDATION FOR GENETIC AND RARE DISEASES EJP RD
INFECTIOUS DISEASES, AIDS AND CLINICAL IMMUNOLOGY RESEARCH CENTER CARE
NATIONAL CENTER FOR TUBERCULOSIS AND LUNG DISEASES JSC DRTB-HDT
NATIONAL CENTER FOR TUBERCULOSIS AND LUNG DISEASES JSC SMA-TB
DAVID TVILDIANI MEDICAL UNIVERSITY LLC BornToGetThere
Moldova ASOCIATIA OBSTEASCA SANATATE PENTRU TINERI RISE
SOCIETATEA PSIHIATRILOR, NARCOLOGILOR, PSIHOTERAPEUTILOR SI PSIHOLOGILOR
CLINICIENI DIN REPUBLICA MOLDOVA RECOVER-E
UNIVERSITATEA DE STAT DE MEDICINA SI FARMACIE NICOLAE TESTEMITANU DIN
REPUBLICA MOLDOVA RECOVER-E
INSTITUTIA MEDICO-SANITARA PUBLICA - INSTITUTUL DE FTIZIOPNEUMOLOGIE "CHIRIL
DRAGANIUC" CARE
INSTITUTIA MEDICO-SANITARA PUBLICA - INSTITUTUL DE FTIZIOPNEUMOLOGIE "CHIRIL
DRAGANIUC" DRTB-HDT
Ukraine INTERNATIONAL CHARITABLE FUND OMNI-NET FOR CHILDREN EUROlinkCAT
NATIONAL CANCER INSTITUTE VOGAS
STATE INSTITUTION PUBLIC HEALTH CENTER OF THE MINISTRY OF HEALTH OF UKRAINE CARE
9 STATE INSTITUTION PUBLIC HEALTH CENTER OF THE MINISTRY OF HEALTH OF UKRAINE SoNAR-GlobalHorizon Europe - Structure 10
Horizon Europe – Cluster 1 - Health
Aims:
• to contribute to the promotion of social cohesion and inclusiveness and
the health and well-being of people.
• to help develop “an economy that works for people” by supporting
research (and coordination) in order to make innovative, high-quality
health technologies and health care both available and affordable for
citizens;
• and to make health care systems more accessible and sustainable,
including through the digital transformation of health and care.
11Horizon Europe – Cluster 1 - Health
Challenges:
• a complex, evolving demography (ageing, multi-morbidities,… )
• achieving greater resilience and equity in our healthcare systems;
• the need to be better prepared for the accelerating pace of change
and possible shocks to our societies.
12Horizon Europe – Cluster 1 - Health
Role of Research & Innovation:
• advance knowledge and capabilities,
• improve understanding of health and diseases,
• develop innovative methodological and technological solutions to better manage health
and diseases,
• design sustainable approaches for the digital transformation and delivery of integrated,
person-centred and equitable health and care services.
Budget for Pillar 2: € 47.2 billion (2021-2027) (29 September 2020):
• Cluster 1 – “Health”: € 6.9 billion
13Horizon Europe – Cluster 1 - Health
Six “Destinations”:
1. Staying healthy in a rapidly changing society
2. Living and working in a health-promoting environment
3. Tackling diseases & reducing disease burden
4. Ensuring access to innovative, sustainable & high-quality Healthcare
5. Unlocking the full potential of new tools, technologies and digital solutions
for a healthy society
6. Maintaining an innovative, sustainable & globally competitive health industry
14Horizon Europe – Cluster 1 - Health
Cross-cutting issues
• Gender: integration of gender dimension in R&I further strengthened
+ gender equality plan becomes an eligibility criterion for public bodies
• Ethics and Integrity remain absolute priorities;
• Open Science Practices will continue to expand;
• Social sciences and Humanities should continue to be taken into account;
• International Cooperation will remain a key feature and opportunity of the
framework programme, which is particularly important for health research.
15Horizon Europe – Cluster 1 - Health
Keep informed. Get involved.
• Register to receive the latest updates of developments.
• Reach out to National Contact Points.
• Become an independent evaluator for HE proposals
ALL this can be done via EC portal for Funding & Tenders Opportunities.
https://ec.europa.eu/info/funding-tenders/opportunities/portal
• General information on Horizon Europe: https://ec.europa.eu/info/horizon-europe
• You can also follow us on Twitter @EUScienceInnov
16Thank you General information on Horizon Europe: https://ec.europa.eu/info/horizon-europe Funding & Tenders Opportunities portal: https://ec.europa.eu/info/funding-tenders/opportunities/portal Twitter: @EUScienceInnov
You can also read
